Evolus (EOLS) Reports Prelim Q4 Revenue of $34.7M
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Business Update Support Positive Thesis on Evolus (EOLS), Guidance Looks Conservative, Reiterate Overweight - Cantor Fitzgerald
January 26, 2022 2:30 PM ESTCantor Fitzgerald analyst Louise Chen reiterated an Overweight rating and $20.00 price target on Evolus (NASDAQ: EOLS), following the company's recent business update.
The analyst quotes: "Today (1/26), EOLS provided a business update that supports our positive investment thesis on the stock. The company: 1) exceeded revenue... More
